Currently, there are 58.44M common shares owned by the public and among those 50.29M shares have been available to trade.
The company’s stock has a 5-day price change of 22.71% and 55.06% over the past three months. NARI shares are trading 27.33% year to date (YTD), with the 12-month market performance up to 3.39% higher. It has a 12-month low price of $36.73 and touched a high of $65.94 over the same period. NARI has an average intraday trading volume of 935.88K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.17%, 25.65%, and 37.55% respectively.
Institutional ownership of Inari Medical Inc (NASDAQ: NARI) shares accounts for 89.46% of the company’s 58.44M shares outstanding.
It has a market capitalization of $3.66B and a beta (3y monthly) value of 0.97. The earnings-per-share (ttm) stands at -$1.35. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.17% over the week and 6.89% over the month.
Earnings per share for the fiscal year are expected to decrease by -2171.43%, and 105.75% over the next financial year.
Looking at the support for the NARI, a number of firms have released research notes about the stock. Oppenheimer stated their Outperform rating for the stock in a research note on December 17, 2024, with the firm’s price target at $75. Stifel coverage for the Inari Medical Inc (NARI) stock in a research note released on September 18, 2024 offered a Hold rating with a price target of $50. Leerink Partners was of a view on September 03, 2024 that the stock is Market Perform, while Deutsche Bank gave the stock Buy rating on August 09, 2024, issuing a price target of $68. William Blair on their part issued Outperform rating on July 25, 2024.
